Delivery Order SPE2DB20D2002-SPE2DB24FL49K

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $6.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL49K
    Delivery Order

This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL49K, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,510,468 methylphenidate ER 27 mg tablets, 100 count, with a ceiling value of $6,768.27 and a performance period ending on May 7, 2024. This is a delivery order contract with a firm-fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:29 AM